NCT00069238 2022-02-24Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell LymphomasNational Institutes of Health Clinical Center (CC)Phase 2 Completed31 enrolled 12 charts
NCT00040846 2020-01-29Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesFred Hutchinson Cancer CenterPhase 2 Completed60 enrolled 10 charts
NCT00118352 2017-05-30Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed12 enrolled 10 charts